Private Advisor Group’s GSK GSK Stock Holding History

Private Advisor Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.85M	Sell	51,606 -3,129	-6%	-$170K	0.01%	885
2025 Q4	$2.68M	Buy	54,735 +4,613	+9%	+$215K	0.01%	902
2025 Q3	$2.16M	Buy	50,122 +4,069	+9%	+$159K	0.01%	975
2025 Q2	$1.77M	Sell	46,053 -1,639	-3%	-$62.6K	0.01%	1031
2025 Q1	$1.85M	Sell	47,692 -7,121	-13%	-$261K	0.01%	934
2024 Q4	$1.85M	Sell	54,813 -13,955	-20%	-$502K	0.01%	924
2024 Q3	$2.81M	Sell	68,768 -6,552	-9%	-$268K	0.02%	744
2024 Q2	$2.9M	Sell	75,320 -4,286	-5%	-$180K	0.02%	694
2024 Q1	$3.41M	Buy	79,606 +9,187	+13%	+$379K	0.02%	593
2023 Q4	$2.61M	Sell	70,419 -6,557	-9%	-$235K	0.02%	659
2023 Q3	$2.79M	Buy	76,976 +8,021	+12%	+$285K	0.02%	590
2023 Q2	$2.46M	Buy	68,955 +7,019	+11%	+$252K	0.02%	637
2023 Q1	$2.2M	Buy	61,936 +1,245	+2%	+$43.6K	0.02%	637
2022 Q4	$717K	Sell	60,691 -2,586	-4%	-$86.1K	0.04%	452
2022 Q3	$1.86M	Sell	63,277 -19,297	-23%	-$731K	0.02%	647
2022 Q2	$4.49M	Buy	82,574 +9,454	+13%	+$522K	0.04%	444
2022 Q1	$3.98M	Sell	73,120 -4,176	-5%	-$227K	0.03%	532
2021 Q4	$4.26M	Sell	77,296 -22,467	-23%	-$1.17M	0.03%	513
2021 Q3	$4.76M	Buy	99,763 +38,673	+63%	+$1.94M	0.03%	540
2021 Q2	$3.04M	Sell	61,090 -3,114	-5%	-$150K	0.03%	593
2021 Q1	$2.86M	Sell	64,204 -1,504	-2%	-$68.3K	0.03%	571
2020 Q4	$3.02M	Buy	65,708 +14,947	+29%	+$687K	0.03%	504
2020 Q3	$2.48M	Sell	50,761 -593	-1%	-$29.7K	0.03%	493
2020 Q2	$2.62M	Buy	51,354 +1,833	+4%	+$94K	0.04%	439
2020 Q1	$2.35M	Sell	49,521 -8,280	-14%	-$442K	0.04%	390
2019 Q4	$3.4M	Sell	57,801 -7,013	-11%	-$390K	0.05%	373
2019 Q3	$3.54M	Sell	64,814 -43,959	-40%	-$2.26M	0.06%	358
2019 Q2	$5.31M	Buy	108,773 +59,367	+120%	+$2.98M	0.1%	235
2019 Q1	$2.58M	Buy	49,406 +6,388	+15%	+$319K	0.05%	363
2018 Q4	$2.06M	Sell	43,018 -9,003	-17%	-$443K	0.05%	379
2018 Q3	$2.61M	Sell	52,021 -1,373	-3%	-$69.8K	0.05%	350
2018 Q2	$2.68M	Buy	53,394 +29,495	+123%	+$1.49M	0.04%	213
2018 Q1	$1.17M	Sell	23,899 -13,587	-36%	-$633K	0.05%	375
2017 Q4	$1.74M	Sell	37,486 -24,895	-40%	-$1.15M	0.07%	277
2017 Q3	$3.17M	Buy	62,381 +4,170	+7%	+$212K	0.08%	260
2017 Q2	$3.07M	Buy	58,211 +844	+1%	+$45K	0.08%	242
2017 Q1	$3.01M	Buy	57,367 +6,962	+14%	+$353K	0.08%	248
2016 Q4	$2.46M	Buy	50,405 +7,731	+18%	+$382K	0.08%	257
2016 Q3	$2.32M	Sell	42,674 -7,556	-15%	-$414K	0.09%	225
2016 Q2	$2.74M	Buy	50,230 +14,202	+39%	+$748K	0.11%	188
2016 Q1	$1.84M	Sell	36,028 -19,523	-35%	-$972K	0.09%	234
2015 Q4	$2.8M	Buy	55,551 +3,245	+6%	+$165K	0.13%	165
2015 Q3	$2.51M	Buy	52,306 +7,460	+17%	+$388K	0.14%	158
2015 Q2	$2.34M	Buy	44,846 +5,173	+13%	+$291K	0.11%	188
2015 Q1	$2.29M	Buy	39,673 +6,606	+20%	+$379K	0.13%	168
2014 Q4	$1.77M	Buy	33,067 +1,902	+6%	+$106K	0.11%	220
2014 Q3	$1.79M	Buy	31,165 +5,954	+24%	+$365K	0.12%	187
2014 Q2	$1.69M	Buy	25,211 +1,129	+5%	+$76.4K	0.14%	155
2014 Q1	$1.61M	Buy	24,082 +1,358	+6%	+$91.8K	0.17%	142
2013 Q4	$1.52M	Buy	+22,724	New	+$1.47M	0.17%	143

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Private Advisor Group's GSK Position: Q1 2026 in Review

Private Advisor Group reduced its GSK (GSK) stake by 5.7% in Q1 2026, selling an estimated $170K and leaving 51,606 shares worth $2.85M. The position accounts for 0.01% of the portfolio, ranked #885.

Private Advisor Group first reported a position in GSK in Q4 2013 and has held it in 50 quarters since. The position peaked at $5.31M in Q2 2019. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Private Advisor Group held 51,606 shares of GSK worth $2.85M as of Q1 2026.
Private Advisor Group sold 3,129 GSK shares in Q1 2026, an estimated $170K.
GSK made up 0.01% of Private Advisor Group's portfolio in Q1 2026, its #885 holding.
Private Advisor Group first reported a position in GSK in Q4 2013 and has held it in 50 quarters since.
Private Advisor Group's GSK position peaked at $5.31M in Q2 2019.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.